Efficacy and prognostic factors for y-90 radioembolization (Y-90) in metastatic neuroendocrine tumors with liver metastases.

被引：0
|
作者：
Tsang, Erica S.
Loree, Jonathan M.
Davies, Janine Marie
Gill, Sharlene
Liu, David
Ho, Stephen
Kennecke, Hagen F.
机构：
[1] BC Canc, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Virginia Mason Hosp & Med Ctr, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e16180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16180
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
    Tsang, Erica S.
    Loree, Jonathan M.
    Davies, Janine M.
    Gill, Sharlene
    Liu, David
    Ho, Stephen
    Renouf, Daniel J.
    Lim, Howard J.
    Kennecke, Hagen F.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 2020
  • [2] Y-90 Radioembolization of Liver Metastases from Neuroendocrine (NET) Tumors
    Bongini, M.
    Coppa, J.
    Spreafico, C.
    Virdis, M.
    Monteleone, M.
    Chiesa, C.
    Vaiani, M.
    Cascella, T.
    Bhoori, S.
    Flores, M.
    Mazzaferro, V
    [J]. NEUROENDOCRINOLOGY, 2019, 108 : 238 - 238
  • [3] Efficacy and safety of Y-90 radioembolization for colorectal cancer liver metastases.
    Villa Palacios, J.
    Trivino-Ibanez, E.
    Gonzalez-Flores, E.
    Pardo-Moreno, P.
    Rodriguez-Fernandez, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S660 - S661
  • [4] Y-90 radioembolization in the treatment of colorectal cancer that is metastatic to the liver
    Cucci, A. R.
    Martin, E. W., Jr.
    Bloomston, M.
    Schmidt, C. R.
    Mayr, N. A.
    Wei, L.
    Bekaii-Saab, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [5] Safety and efficacy of transarterial Y-90 radioembolisation for liver metastases of neuroendocrine tumours
    Boni, G.
    Bargellini, I.
    Tredici, M.
    Mazzarri, S.
    Farnesi, A.
    Chiacchio, S.
    Traino, A. C.
    Manca, G.
    Guidoccio, F.
    Cioni, R.
    Bartolozzi, C.
    Ricci, S.
    Volterrani, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S747 - S748
  • [6] YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy
    Gunduz, S.
    Ozgur, O.
    Bozcuk, H.
    Coskun, H. S.
    Ozdogan, M.
    Erkilic, M.
    Sindel, T.
    Yildiz, A.
    Yilmaz, S.
    Savas, B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S604 - S604
  • [7] Factors impacting survival in colorectal liver metastases treated with Y-90 radioembolization.
    Villa Palacios, J.
    Trivino-Ibanez, E.
    Ciampi-Dopazo, J.
    Gonzalez-Flores, E.
    Rodriguez-Fernandez, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S661 - S661
  • [8] Treatment of Unresectable Neuroendocrine Liver Tumors with Y-90 Microsphere
    Kucuk, O.
    Lacin, S.
    Oz, I
    Bilgic, S.
    [J]. NEUROENDOCRINOLOGY, 2010, 92 (01) : 42 - 42
  • [9] Y-90 liver radioembolization microsphere prediction and dosimetry
    Costa, Gustavo
    Ruvalcaba, Carlos
    Roncali, Emilie
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [10] Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres
    Demir, Burak
    Soydal, Cigdem
    Kucuk, Nuriye Ozlem
    Celebioglu, Emre Can
    Bilgic, Mehmet Sadik
    Oz, Digdem Kuru
    Elhan, Atilla Halil
    Kir, Kemal Metin
    [J]. ANNALS OF NUCLEAR MEDICINE, 2024,
12345